Rights and permissions
About this article
Cite this article
Long-acting risperidone reduces costs in schizophrenia. Pharmacoecon. Outcomes News 443, 6 (2003). https://doi.org/10.1007/BF03277195
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03277195